XML 108 R95.htm IDEA: XBRL DOCUMENT v3.10.0.1
Intangible assets and goodwill - Narrative (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Dec. 31, 2018
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Apr. 20, 2017
Finite-Lived Intangible Assets [Line Items]          
Useful life   7 years      
Amortization of acquired intangible asset   $ 22,877 $ 15,380 $ 0  
Total allocation of IPR&D assets   576,500      
Goodwill $ 82,341 82,341 0    
Goodwill Adjustment 18,000        
Akcea          
Finite-Lived Intangible Assets [Line Items]          
Upfront licensing fee   $ 12,000      
Development And Regulatory Milestone Payment Obligations, Period   30 days      
Non-collaborative Arrangement Transactions | Akcea          
Finite-Lived Intangible Assets [Line Items]          
Development milestone payment obligations 6,000 $ 6,000      
Emflaza          
Finite-Lived Intangible Assets [Line Items]          
Development milestone payment obligations 14,400 14,400      
Emflaza asset acquisition          
Finite-Lived Intangible Assets [Line Items]          
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles         $ 148,400
Marathon Pharmaceuticals, LLC          
Finite-Lived Intangible Assets [Line Items]          
Development milestone payment obligations 6,000 6,000      
Intellectual Property          
Finite-Lived Intangible Assets [Line Items]          
Amortization of acquired intangible asset   22,900 $ 15,400    
Finite-Lived Intangible Assets, Accumulated Amortization $ 38,300 $ 38,300